Ms. Vaneeta Dandenault is the Executive Vice President of Clinical Operations at DP Clinical and has over 28 years of clinical research experience, including more than 25 years at DP Clinical. She is responsible for the strategy, implementation, and oversight of all clinical trial programs and brings a passion and uncompromising drive for research excellence to company’s clinical programs.
Prior to DP Clinical, Ms. Dandenault was a Clinical Research Associate at MedImmune, Inc. in Gaithersburg, MD, where she managed transplant rejection, respiratory, and graft-versus-host disease (GVHD) studies. Prior to MedImmune, Ms. Dandenault was a Clinical Research Associate at Fidia Pharmaceutical Corporation in Washington, DC, where she managed acute spinal cord injury and Parkinson’s Disease studies.
Ms. Dandenault holds a BA in Political Science and International Studies from Michigan State University in Lansing, Michigan.
